Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up
- PMID: 15039412
- DOI: 10.1001/jama.291.12.1456
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up
Abstract
Context: Because menorrhagia is often a reason for seeking medical attention, it is important to consider outcomes and costs associated with alternative treatment modalities. Both the levonorgestrel-releasing intrauterine system (LNG-IUS) and hysterectomy have proven effective for treatment of menorrhagia but there are no long-term comparative studies measuring cost and quality of life.
Objective: To compare outcomes, quality-of-life issues, and costs of the LNG-IUS vs hysterectomy in the treatment of menorrhagia.
Design, setting, and participants: Randomized controlled trial conducted between October 1, 1994, and October 6, 2002, and enrolling 236 women (mean [SD] age, 43 [3.4] years) referred to 5 university hospitals in Finland for complaints of menorrhagia.
Interventions: Participants were randomly assigned to treatment with the LNG-IUS (n = 119) or hysterectomy (n = 117) and were monitored for 5 years.
Main outcome measures: Health-related quality of life (HRQL) as measured by the 5-Dimensional EuroQol and the RAND 36-Item Short-Form Health Survey, other measures of psychosocial well-being (anxiety, depression, and sexual function), and costs.
Results: After 5 years of follow-up, 232 women (99%) were analyzed for the primary outcomes. The 2 groups did not differ substantially in terms of HRQL or psychosocial well-being. Although 50 (42%) of the women assigned to the LNG-IUS group eventually underwent hysterectomy, the discounted direct and indirect costs in the LNG-IUS group (2817 dollars [95% confidence interval, 2222 dollars-3530 dollars] per participant) remained substantially lower than in the hysterectomy group (4660 dollars [95% confidence interval, 4014 dollars-5180 dollars]). Satisfaction with treatment was similar in both groups.
Conclusions: By providing improvement in HRQL at relatively low cost, the LNG-IUS may offer a wider availability of choices for the patient and may decrease costs due to interventions involving surgery.
Comment in
-
Evaluating gynecological surgical procedures: trials and tribulations.JAMA. 2004 Mar 24;291(12):1503-4. doi: 10.1001/jama.291.12.1503. JAMA. 2004. PMID: 15039418 No abstract available.
Similar articles
-
Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.Am J Obstet Gynecol. 2013 Dec;209(6):535.e1-535.e14. doi: 10.1016/j.ajog.2013.08.041. Epub 2013 Aug 30. Am J Obstet Gynecol. 2013. PMID: 23999423 Clinical Trial.
-
The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.Acta Obstet Gynecol Scand. 2009;88(12):1389-96. doi: 10.3109/00016340903297150. Acta Obstet Gynecol Scand. 2009. PMID: 19878089 Clinical Trial.
-
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.Lancet. 2001 Jan 27;357(9252):273-7. doi: 10.1016/S0140-6736(00)03615-1. Lancet. 2001. PMID: 11214131 Clinical Trial.
-
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. doi: 10.1002/14651858.CD002126.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3 PMID: 16235297 Updated. Review.
-
The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.Contraception. 2007 Jun;75(6 Suppl):S152-4. doi: 10.1016/j.contraception.2007.01.003. Epub 2007 Feb 23. Contraception. 2007. PMID: 17531608 Review.
Cited by
-
Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation.Health Technol Assess. 2024 Aug;28(41):1-228. doi: 10.3310/VBXX6307. Health Technol Assess. 2024. PMID: 39246007 Free PMC article.
-
The Effects of Hormonal and Non-Hormonal Intrauterine Devices on Female Sexual Function: A Systematic Review.Int J Sex Health. 2023 Jan 11;35(1):67-81. doi: 10.1080/19317611.2022.2155898. eCollection 2023. Int J Sex Health. 2023. PMID: 38596762 Free PMC article.
-
Effectiveness of treating menorrhagia using microwave endometrial ablation at a frequency of 2.45 GHz.World J Clin Cases. 2023 Aug 26;11(24):5653-5659. doi: 10.12998/wjcc.v11.i24.5653. World J Clin Cases. 2023. PMID: 37727709 Free PMC article.
-
Effectiveness of microwave endometrial ablation combined with hysteroscopic transcervical resection in treating submucous uterine myomas.World J Clin Cases. 2022 Dec 26;10(36):13200-13207. doi: 10.12998/wjcc.v10.i36.13200. World J Clin Cases. 2022. PMID: 36683642 Free PMC article.
-
Mirena: Just a contraceptive device? or A modality with diverse clinical applications !J Family Med Prim Care. 2022 Sep;11(9):5031-5037. doi: 10.4103/jfmpc.jfmpc_2545_20. Epub 2022 Oct 14. J Family Med Prim Care. 2022. PMID: 36505540 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
